

"Behavior-first weight care that makes GLP-1 coverage sustainable"
Embla delivers weight and cardiometabolic care through a fully managed digital platform combining psychology-led coaching with low-dose GLP-1 medication. The program addresses obesity, prediabetes, and metabolic risk using an ACT-based behavioral approach. Members work with coaches, clinicians, and dietitians through the Embla app to achieve lasting results. Real-world data shows members lose an average of 16.7% body weight in 12 months while using 55% less GLP-1 than traditional protocols. The program includes structured medication tapering and long-term support to prevent regain. Employers get a cost-effective cardiometabolic carve-out with zero administrative burden and measurable outcomes.


75
Team Members
2021
Founded
Digital Health
Sector
Hybrid
Work Environment
A world where weight care drives long-term metabolic health, not temporary fixes. Where behavior change forms the foundation and medication serves as a temporary amplifier. Where employers can offer effective obesity treatment without runaway costs.
Embla exists to transform obesity treatment by combining behavior-first coaching with responsible GLP-1 management, delivering sustainable weight loss and improved cardiometabolic health at a fraction of traditional costs.